Amicus Therapeutics
FOLD
#3311
Rank
NZ$8.13 B
Marketcap
NZ$25.91
Share price
0.00%
Change (1 day)
94.92%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2023 (TTM): NZ-$1.04

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.20. In 2022 the company made an earnings per share (EPS) of NZ-$1.47 an increase over its 2021 EPS that were of NZ-$1.65.

EPS history for Amicus Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$1.04-28.79%
2022NZ-$1.47-10.87%
2021NZ-$1.65-14.02%
2020NZ-$1.91-29.14%
2019NZ-$2.70-18.82%
2018NZ-$3.331.64%
2017NZ-$3.2722%
2016NZ-$2.6826.05%
2015NZ-$2.1327.96%
2014NZ-$1.66-19.13%
2013NZ-$2.065.5%
2012NZ-$1.95-15.5%
2011NZ-$2.31-35.18%
2010NZ-$3.56610.71%
2009NZ-$0.50-83.91%
2008NZ-$3.11-86.15%
2007NZ-$22.47-85.97%
2006NZ-$160.2082.72%
2005NZ-$87.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
NZ$7.29-3,806.93%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
NZ$4.22-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.15-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
NZ-$0.27 36.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03576-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.68-445.45%๐Ÿ‡บ๐Ÿ‡ธ USA